Candriam S.C.A. Quanterix Corp Transaction History

Candriam S.C.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	BUY	$15.06 - $30.65 $225,900 - $459,750	15,000 Added 20.0%	90,000 $1.46 Million
Q1 2022 May 13, 2022	BUY	$23.26 - $42.41 $1.74 Million - $3.18 Million	75,000 New	75,000 $2.19 Million
Q2 2020 Jul 23, 2020	SELL	$19.21 - $28.53 $595,510 - $884,430	-31,000 Closed	0 $0
Q3 2019 Oct 21, 2019	BUY	$21.72 - $35.38 $152,040 - $247,660	7,000 Added 29.17%	31,000 $1,000
Q2 2019 Aug 01, 2019	BUY	$20.59 - $35.2 $247,080 - $422,400	12,000 Added 100.0%	24,000 $807,000
Q1 2019 May 02, 2019	BUY	$17.28 - $25.83 $207,360 - $309,960	12,000 New	12,000 $310,000

157

33.2M

30.6K

25.1K

Ticker QTRX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,987,600
Market Cap $348M
Description
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.